Press Room
Assay Genie in the News
Featured Media & Press Coverage
Discover Assay Genie’s latest media features, press mentions, and industry highlights that showcase our role in advancing life sciences. From national radio interviews and newspaper articles to online spotlights and international coverage, our story has been shared widely across trusted outlets.
Dr Seán Mac Fhearraigh and Dr Colm Ryan, co-founders of Assay Genie, spoke about Assay Genie’s rapid antibody test, highlighting its potential to speed up a safe return to normal life. With potential applications across public health, workplaces, travel, and events, this innovative diagnostic highlights Assay Genie’s role in supporting pandemic recovery and advancing global healthcare solutions.
The Sun covered Assay Genie’s rapid antigen test, emphasising its speed and reliability in detecting COVID-19. Designed to provide a fast and accessible screening tool, the test offers significant potential for use in workplaces, schools, travel, and community settings to help control the spread of the virus. Highlighting Assay Genie’s role in advancing innovative diagnostics, the article showcases how rapid testing solutions can support public health efforts and enable a safer, faster return to normal life.
The University Times highlights how Ireland’s scientific community is actively mobilizing against COVID-19 by developing novel technologies and testing solutions, including Assay Genie (formerly “Reagent Genie”), whose founders Colm Ryan (CEO) and Seán Mac Fhearraigh (CTO) created a rapid coronavirus antibody/antigen kit using methods akin to pregnancy tests.
The CareersPortal article highlights how medtech and pharmaceutical companies are playing a critical role in Ireland’s response to the COVID-19 crisis, spotlighting innovations such as rapid testing, diagnostics, vaccine support, and supply chain mobilization. It underscores how firms across the sector are contributing by accelerating test development, scaling manufacturing, and collaborating with health services—emphasizing how industry efforts complement public health measures in combating the pandemic.
The Business Post article reports that three Irish firms are scaling up their COVID-19 test production lines to meet rising demand, reinforcing Ireland’s capacity to respond to diagnostic needs. It examines how these companies are expanding manufacturing, innovating testing methods, and forming collaborations to deliver tests more quickly and broadly — highlighting the growing role of local industry in supporting pandemic response and public health infrastructure.
Tipperary native Dr. Colm Ryan, co-founder and CEO of Assay Genie, together with co-founder Dr. Seán Mac Fhearraigh, has developed a groundbreaking 15-minute COVID-19 rapid test kit designed to support hospitals in Ireland, the UK, and beyond. Reported in TipperaryLive, the innovative test uses simple, pregnancy-style technology to quickly detect coronavirus antibodies, offering healthcare providers a reliable and accessible diagnostic tool. This feature highlights Assay Genie’s role in accelerating pandemic response and reinforcing Ireland’s contribution to global healthcare innovation.
The Irish Post article reports that Dublin-based life science firm Assay Genie is developing a 15-minute COVID-19 antigen test that could soon be available in pharmacies, priced as low as €15. The test—using a nasal swab—claims accuracy between 92% and 98%, offering a rapid alternative to PCR diagnostics. The article quotes Colm Ryan, CEO of Assay Genie, explaining that the speedy and affordable nature of this test could make it accessible for widespread use in community settings such as pharmacies.
UCD graduates Seán Mac Fhearraigh and Colm Ryan co-founded Assay Genie, which has created a 15-minute COVID-19 rapid test kit capable of producing results from a single drop of blood. UCD Foundation. The test is being prepared for global release in response to the urgent need for faster diagnostics.
Silicon Republic profiled Assay Genie as an Irish start-up developing rapid COVID-19 testing kits to support global efforts during the pandemic. The company aims to provide a faster, more accessible alternative to standard testing, positioning itself as part of Ireland’s innovation response to COVID-19.
The Irish Independent reports that Assay Genie, an Irish life sciences company, has developed a rapid COVID-19 test kit that can confirm infection in just 15 minutes. This innovative diagnostic offers a faster and more affordable alternative to traditional PCR testing, with potential applications in hospitals, workplaces, and community settings. The article highlights Assay Genie’s contribution to Ireland’s pandemic response and its role in delivering cutting-edge solutions to support global healthcare.
The Irish Independent reports that Assay Genie, has developed a 15-minute COVID-19 antigen test that could soon be made available through pharmacies. Independent The article names Colm Ryan (CEO) and Seán Mac Fhearraigh (CTO) as leading the project, discussing the test’s affordability (estimated between €15 and €25), its projected accuracy (around 92%–98%), and its function via a nasal swab.
IrishTechNews highlights Reagent Genie—the parent brand of Assay Genie—cofounded by Colm Ryan and Seán Mac Fhearraigh. Irish Tech News Featured as a “scientific Amazon,” Reagent Genie offers life science products including assays, antibodies, and ELISA kits through dedicated e-commerce platforms. Irish Tech News With offices in Dublin and London, and validation across Europe and the U.S., the company empowers R&D scientists with high-quality reagents and technical support across 45,000+ products.
Interview with Sean Mac Fhearraigh, co-founder and Chief Scientific Officer at Assay Genie. Sean shares his journey from academic cancer researcher to successful entrepreneur. We delve into the challenges of transitioning from science to business, raising funds, and growing Assay Genie into a multimillion-euro enterprise.
In the Newstalk Irish-language podcast “Splanc le Cuán Ó Flartharta”, Dr. Seán Mac Fhearraigh, co-founder and Chief Technology Officer of Assay Genie, discusses the company’s breakthrough in developing a 15-minute rapid COVID-19 testing kit. Speaking about the challenges and opportunities of creating fast, reliable diagnostics during a global pandemic, Seán highlights how Assay Genie’s test could transform public health by enabling quicker detection, widespread screening, and safer community reopening.
In the Newstalk “Lunchtime Live Highlights” podcast episode “15 Minute Covid Testing”, Dr. Colm Ryan, co-founder and CEO of Assay Genie, discusses the company’s development of a 15-minute COVID-19 rapid test. He explains how this breakthrough diagnostic could be used in workplaces, schools, and pharmacies to accelerate safe reopening and strengthen public health responses. This media feature highlights Assay Genie’s leadership in delivering fast, accessible testing solutions during the pandemic.
In a feature on The Ray D’Arcy Show (RTÉ Radio 1), Seán Mac Fhearraigh, co-founder and CTO of Assay Genie, explains the design, function, and potential impact of the company’s rapid 15-minute COVID-19 test. He outlines how this fast diagnostic could be used in community settings such as pharmacies, clinics, and workplaces, emphasizing its role in enabling safer reopening and improving screening access. This broadcast underscores Assay Genie’s profile as a leader in rapid diagnostics innovation in Ireland and beyond.
In the RTÉ RNAG segment titled “Seán Mac Fhearraigh, Assay Genie” (Adhmhaidin), Seán Mac Fhearraigh, co-founder and CTO of Assay Genie, discusses the company’s work on a rapid COVID-19 test capable of detecting infection in just minutes. RTÉ He outlines how this innovation could help with faster screening in community settings and strengthen Ireland’s diagnostic capabilities during the pandemic.
Do you have any questions?
Additional Resources
